OSCR
Strong BuyFull HouseFLAGOscar Health, Inc. · Healthcare · United States · $9.4B · Avg Vol: $175M/d
Full House: Strong business, sensible price, market agrees. The rare full house.
Passes quantitative thresholds, but net insider selling occurred over the last 90 days. While EPS revisions are strongly positive, the negative insider signal triggers a flag per protocol.
ABOUT OSCAR HEALTH, INC.
Read
Oscar Health, Inc. is a technology-driven health insurance company focused on the individual and family plan market in the United States. The company utilizes a proprietary full-stack technology platform to simplify the member experience, coordinate care, and lower healthcare costs. Oscar's competitive advantage is driven by its high member engagement, personalized virtual care integration, and strategic partnerships with major provider networks.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.1B | 5.9B | 9.2B | 11.7B | 41.6% | 15.3B | 18.7B | 20.3B | 31.7% |
| EPS | -2.85 | -1.22 | 0.10 | -1.69 | — | 1.30 | 1.75 | 1.88 | 166.0% |
| Shares | 216.3M | 229.4M | 250.5M | 297.7M | +37.6% | 273.5M | — | — | — |
| Debt | 298.0M | 298.8M | 299.6M | 430.1M | 13.0% | 482.1M | — | — | — |
| Equity | 890.4M | 804.0M | 1.0B | 977.6M | 3.2% | — | — | — | — |
| Op CF | 380.3M | -272.2M | 978.2M | 1.1B | 42.3% | 4.4B | — | — | — |
| Inv CF | -226.5M | 577.2M | -1.4B | -241.1M | — | — | — | — | — |
| Fin CF | 301.1M | 6.4M | 68.4M | 399.2M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of OSCR are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| OSCR | Oscar Health, Inc.(you) | $9.4B | 98 | Strong Buy |
| MOH | Molina Healthcare, Inc. | $10.4B | 71 | Buy |
| CNC | Centene Corporation | $32.0B | 93 | Strong Buy |
| PGNY | Progyny, Inc. | $2.0B | 98 | Strong Buy |
| HUM | Humana Inc. | $46.3B | 89 | Strong Buy |
| CI | The Cigna Group | $73.7B | 92 | Strong Buy |
| CLOV | Clover Health Investments, Corp. | $2.2B | 79 | Buy |
| ELV | Elevance Health, Inc. | $85.5B | 90 | Strong Buy |
| CVS | CVS Health Corporation | $119.0B | 93 | Strong Buy |
| ALHC | Alignment Healthcare, Inc. | $2.8B | 59 | Hold |
Peer medians: ROE -31.0% · P/E 25.2x · Gross margin 58.3%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.